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Novelty statement 
• This is the largest study in the UK to investigate associations between ethnicity, deprivation and 
glycaemic-control using a large nationally representative sample of children with type 1 diabetes, 
from all major ethnic groups. 
• Black and mixed ethnicity children had poorest glycaemic-control. Greater deprivation was 
associated with worse glycaemic-control in all ethnicities.  
• Ethnicity, deprivation and treatment regimen were independentely associated with glycaemic 
control. Results suggest that increasing insulin pump use in ethnic minority and more 
deprived children will help these groups achieve better glycaemic control. 
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Abstract 
Background The impact of ethnicity and socioeconomic status (SES) on glycaemic control during childhood 
Type 1 Diabetes (T1D) is poorly understood in England/Wales. 
Methods We studied 18,478 participants with T1D (<19 years) attending diabetes clinics in England/Wales 
and included in 2012-13 National Paediatric Diabetes Audit. Self-identified ethnicity was categorized as 
white, Asian, black, mixed, other and ‘not-stated’ (did not to divulge ethnicity). A small area measure of SES 
was estimated from Index of Multiple Deprivation. Multiple linear regression was used to assess impact of 
ethnicity and SES on glycaemic control (mean HbA1c levels) accounting for age, gender and diabetes 
duration. Impact of insulin pump use on the ethnicity/SES-HbA1c associations was tested in 13,962 children. 
Results All ethnic minorities had higher mean HbA1c compared to white children, with largest differences 
observed in black and mixed ethnicities (8mmol/mol [2.9%], 95%CI 5-11 and 7mmol/mol [2.8%], 5-9 
respectively). Lower SES was associated with higher mean HbA1c with a dose effect. The lowest SES group 
had 7mmol/mol [2.8%] (6-8) higher mean HbA1c compared to the highest SES group, adjusted for ethnicity. 
Estimates for ethnicity were attenuated but significant on adjustment for SES. Less non-white (white 20.3 
vs Black 5.5%) and deprived (Least deprived 21.1 vs most deprived 13.2%) children were on insulin pump 
therapy.  Ethnicity and SES remained significant predictors of HbA1c after accounting for insulin pump use.  
Conclusion The association between ethnicity and glycaemic control persists after adjustment for 
deprivation and pump use. An alternative approach to intensive insulin therapy might benefit these 
vulnerable children.  
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Introduction 
Inequalities in Type 1 Diabetes (T1D) treatment and disparities in glycaemic control in children and young 
people are well documented and are associated with severe short-term (hypoglycaemia and diabetic 
ketoacidosis) and long-term complications (nephropathy, retinopathy, neuropathy and cardiovascular 
disease) (1). Additionally, poor glycaemic control impacts adversely on family dynamics and tracks from 
childhood into adulthood increasing the lifetime risk of vascular complications and significantly reducing 
life expectancy (2, 3).  Despite robust evidence showing the efficacy of intensive insulin regimens in 
improving outcomes, inequalities in treatments and outcomes related to T1D remain strong even in 
countries with tax-funded universal healthcare systems (4-8).  
Research from outside the UK shows that ethnic minority children and those from lower Socioeconomic 
Status (SES) have consistently poorer glycaemic control (4, 6, 7, 9-11). Studies on health inequalities related 
to T1D treatment and glycaemic control in England and Wales have been conducted on smaller study 
samples often restricted to particular clinics or regions (4, 12-14). The role of ethnicity has not been 
comprehensively studied often due to low numbers of ethnic minorities. Some studies also showed 
contradictory results (14). Previously observed differences in glycaemic control between ethnic groups 
could be a reflection of greater deprivation in ethnic minorities and/or poorer access to intensive 
treatment regimens. Additionally, most of the evidence for inequalities in T1D health care processes, 
treatment and outcomes originate from North America, northern Europe and Australasia, where ethnic 
groupings and/or healthcare differ to the UK (5, 6, 15-18). Thus there is a strong need to investigate social 
and ethnic differences in glycaemic control in children in England and Wales. 
The main aim of this study is to investigate whether ethnicity and SES are associated with glycaemic  
control in children with T1D using a nationwide population-based register that includes almost all T1D 
people under nineteen years of age representing all major ethnic groups with reliable measures of ethnicity 
and deprivation in England and Wales. We wanted to identify ethnic minority groups with the worst 
glycaemic control. Additionally, we wanted to investigate if ethnic differences in glycaemic control are 
independent of SES and treatment regimen and if ethnicity interacts with SES in its association with 
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glycemic control. Differences if any in glycaemic control between white and ethnic minority children that 
appear to be mediated by modifiable factors such as treatment regimen will provide opportunities for 
targeted interventions.  
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Methods 
Data for this study was obtained from the National Paediatric Diabetes Audit (NPDA) for England and 
Wales(19). The NPDA is commissioned and sponsored by the Healthcare Quality Improvement Partnership 
as part of their National Clinical Audit Programme and was started in 2004 and reached 100% participation 
rate in 2012. It includes demographic and outcome data on almost all children with type 1 and type 2 
diabetes under 19 years of age and treated at one of the 178 paediatric diabetic clinics. This study was 
based on data collected during the 2012-13 audit year (1st April 2012 – 31st March 2013). Inclusion criteria 
comprised: a diagnosis of T1D (for a minimum of six months to allow for stabilisation of diabetes control), 
the participant had to be <19 years of age on the first day of the audit, a minimum of one visit to a clinic 
during the audit year and have recorded information on ethnicity and postcode. During the 2012-13 audit 
year, 23,097 people <19 years of age were recorded as having T1D, of whom 19,122 people were eligible to 
be included in the study. 
 
Study measurements  
As per recommendations from the National Institute of Health and Care Excellence (NICE), a child with T1D 
is offered an integrated package of care by a multidisciplinary team at a clinic 2-4 times per year (more 
frequent when glycaemic control is poor). The team consists of paediatric endocrinologists/diabetologists, 
diabetes specialist nurses, dieticians and interpreters if needed. HbA1c levels along with height and weight 
are meant to be recorded at each visit. Other clinical parameters such as blood lipids are recorded annually. 
All demographical and clinical parameters are measured systematically across all clinics enabling 
comparison.  
The outcome of interest was glycaemic control measured by HbA1c levels. HbA1c values recorded as 
percentages were converted to mmol/mol using the formula: (HbA1c value in percentage-2.15)*10.929. We 
calculated mean HbA1c values from all clinic visits in the audit year for each child. Both age at diagnosis and 
age at clinic visit were calculated by subtracting the date of diagnosis from date of birth and date of clinic 
visit from date of birth respectively. Duration of diabetes was calculated by subtracting the date at first visit 
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in the audit year from the date of diagnosis of T1D. Insulin treatment regimen; daily injections (non-pump 
therapy) or continuous subcutaneous insulin infusion (CSII) (pump therapy) was recorded at each visit. The 
first recorded entry in the audit year for ethnicity and treatment regimen was used in the analysis. 
For this study the main predictors of diabetes control were ethnicity and SES. Participants (or their parents) 
were asked to self-identify their ethnicity when they visited a clinic. They were given the option to choose 
one of the fifteen categories as recommended by the Information Standards Board (ISB) for Health and 
Social Care. Participants were also given the option to decline identifying their ethnicity. For the purpose of 
this study, the fifteen ethnic categories were collapsed into six broad groups: white, Asian, black, mixed, 
other and ‘not stated’ (those who declined).  
Socioeconomic status (SES) was derived from postcode using indices of Multiple Deprivation (IMD) 2010 for 
England, and Welsh Indices of Multiple Deprivation 2008 for Wales. Although these two countries 
use slightly differing indices to define deprivation, adjustment can be made to align the two 
techniques (20). The IMD is a small geographical area measure of deprivation. IMD is a multidimensional 
index and scores are derived from a weighted combination of several indicators across seven distinct 
measures of deprivation including income, employment, education skills and training, health, barriers to 
housing and services, living environment and crime (21). It captures the ‘relative’ deprivation experienced 
by an individual living in an area. IMD scores are calculated at the level of Lower Super Output Areas (LSOA) 
with each area comprising 1500 individuals on average. IMD rank scores were grouped into quintiles for 
analysis, with the first and fifth quintiles corresponding to the least and most deprived respectively.   
Of the 19,122 children eligible to be included, 24 lacked data on gender, 360 on SES, and 260 on HbA1c. This 
left 18,478 children with T1D (96.6% of the eligible sample) with data on age, gender, diabetes duration, 
ethnicity and SES and were included in the main analysis to assess associations between ethnicity, SES and 
glycaemic control. A smaller sample of 13,962 participants with data on treatment regimen and all other 
covariates was included in a sub-analysis to assess the effects of treatment regimen on associations 
between ethnicity, SES and glycaemic control. We investigated whether the 4,516 excluded participants 
due to missing data on treatment regimen differed from the 13,962 children included in the sub-analysis. 
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We compared the two groups on all covariates using univariable linear regression or Chi square tests for 
differences of proportions for continuous and categorical variables respectively.   
Statistical analysis 
Continuous variables are presented as mean values with standard deviations and categorical variables as 
frequencies. Associations between ethnicity and SES and other covariates were analysed using univariable 
linear regression or Chi square tests for differences of proportions for continuous and categorical variables 
respectively.  
 
Multivariable linear regression models were fitted with mean HbA1c as the principle outcome and ethnicity 
or SES as the primary predictor (Models 1 and 2 respectively) to assess associations. Model 3 included both 
predictors to assess mutually adjusted associations of ethnicity and SES.. All models were adjusted for 
child’s age during the audit year (years), gender and diabetes duration (years). For linear regression 
analyses, assumptions of linearity for continuous variables and constant variance of the standardized 
residuals were assessed by plotting the residuals against the fitted values.  Model fit of the three models 
was compared using R2 which represents the proportion of variation in HbA1c explained by the model. 
 
Model 1, with SES as the main predictor, was then run stratified by ethnicity to assess whether the 
association between SES and HbA1c were similar across all ethnic groups. Interactions between ethnicity 
and SES were tested using likelihood ratios tests. Robust standard errors allowing for clustering of children 
within clinics were used for all linear regression models. 
 
A sub-analysis was performed using adjustments for the same covariates as in Model 3 above but restricted 
to the smaller study sample of 13,962 children with information on treatment regimen to assess if the 
latter could explain differences in glycaemic control by ethnicity or SES.   
 
Further analysis was performed for the association between ethnicity, SES and HbA1c (using the same 
adjustments for covariates as described above) by fitting linear multilevel models which take into account 
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random effects that vary across clinics. As multilevel modelling yielded the same results as multivariable 
linear regression, we present results from the former in Supplemental Table 1. All statistical analyses were 
conducted using STATA 13 (College Station, TX, USA). 
 
The study protocol was reviewed by University College London (UCL) Research Ethics Committee which 
decided that ethics approval was not required. The NPDA has section 251 approval to collect patient 
identifiable information for the purpose of audit. For this study all participants were pseudonomised 
making them unidentifiable. The study is registered with the R&D office, Institute of Child Health, UCL, 
(Project number 14PP08). 
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Results 
 
The mean age of the study sample was 12.76 years (range 1.3 to 19.0 years). Age at first visit in the audit 
year and age at diagnosis differed by ethnicity. On average, ethnic minority children were diagnosed 
younger than white children but differences were small and clinically not relevant. There was no 
statistically significant difference in diabetes duration between ethnic groups. In comparison to children of 
white ethnicity, children of all other ethnicities had higher mean HbA1c levels with highest levels observed 
in black and mixed ethnicity groups (80mmol/mol [9.5%] and 79mmol/mol [9.4%] respectively, Table 1). In 
comparison to the white group, all ethnicities had higher proportions of children in the most deprived 
socioeconomic group (IMD quintile 5). More than half of all black children were in the most deprived 
quintile (52.6%, Table 1). Significant differences were observed in proportions of children on insulin pump 
therapy by ethnicity. For those with information on pump use, the white group had the largest proportion 
on insulin pump therapy (20.3%), whereas the black and ‘not stated’ groups had the lowest proportions 
(5.5% and 5.0% respectively). 
On average age at first visit in the audit year was slightly lower in the most deprived groups (quintiles 4 and 
5) compared to the least deprived group (quintile 1), however differences were clinically not relevant. 
There were no differences in diabetes duration across the quintiles of deprivation. We observed a strong 
positive association between deprivation and mean HbA1c levels (the most deprived quintile had on 
average 7mmol/mol [2.8%] higher HbA1c compared to the least deprived quintile (Table 2)). Similarly, the 
proportions of children on insulin pump therapy decreased with increasing deprivation (13.2% in the most 
deprived group were on insulin pump therapy compared to 21.2% in least deprived group, Table 2). 
The 4,516 children excluded from sub-analysis because of missing data on treatment regimen did not differ 
significantly in age and mean HbA1c from the 13,962 included in the analysis. The two groups differed 
significantly in age at diagnosis (7.53 vs 7.32 years, P<0.05), diabetes duration (5.26 vs 5.41 years, P<0.005) 
and mean IMD scores (20.85 vs 21.74, P<0.05) but differences were unlikely to be meaningful.  
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Both ethnicity and SES were independently and consistently associated with HbA1c levels. However, the 
model with only SES explained slightly more of the variance in HbA1c level compared to the model with only 
ethnicity (R2=0.09 and 0.07 respectively). Compared to the white group, all ethnic minorities (except the 
‘not stated’ group) had higher mean HbA1c after adjustment for age, gender and diabetes duration. Largest 
differences were observed in black and mixed ethnic children (8mmol/mol [2.9%], 95% CI 5.07-10.60 and 
7mmol/mol [2.8%], 4.55-9.08 respectively, after adjustment for age, gender and diabetes duration, Model 
1, Table 3). SES was significantly associated with glycaemic control with a strong apparent dose-effect 
across quintiles. In the regression model with SES only, being in quintiles 2 to 5 was associated with higher 
mean HbA1c, with the most deprived group (quintile 5) having the highest HbA1c (on average 7mmol/mol 
[2.8%] higher HbA1c compared to the least deprived group, Model 2, Table 3). However, after controlling for 
SES, (i.e. the model which included both ethnicity and SES, Model 3, Table 3), the estimates for all ethnic 
groups were attenuated considerably and were no longer significant for the ‘other’ group. In contrast, the 
estimates for deprivation quintiles were only marginally attenuated on adjustment for ethnicity (Model 3, 
Table 3). 
The association between SES and glycaemic control was similar across ethnic groups in stratified analysis, 
i.e. having a lower SES was associated with higher mean HbA1c irrespective of ethnicity. However, being in 
the lowest SES groups (quintiles 4 and 5) and of Asian, mixed, other and ‘not stated’ ethnicity was 
associated with significantly higher mean HbA1c compared to being in the lowest SES groups and having 
white ethnicity (Table 4). For example, being white and in the lowest SES group (quintile 5) was associated 
with 6mmol/mol (2.7%) higher HbA1c when compared to the highest SES group (quintile 1). However, being 
in the lowest SES group and belonging to Asian (7mmol/mol [2.8%], 2.52-11.28), mixed (11mmol/mol 
[3.2%], 6.31-16.21) and ‘not stated’ (10mmol/mol [3.1%], 7.67-12.65) ethnic groups was associated with 
much higher HbA1c levels (Table 4). The interaction test between ethnicity and SES was statistically 
significant (P=0.006).  
In models restricted to those with information on insulin pump therapy (N=13,962), both ethnicity and SES 
remained independently associated with HbA1c levels with a pattern very similar to that observed in 
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regression models with the entire study population. However, on adjustment for pump therapy being in 
the Asian group or in deprivation quintile 2 was no longer significantly associated with higher HbA1c 
(Model4, Table 5). Adjustment for pump therapy marginally attenuated the estimates for the black and the 
more deprived groups (quintiles 3 to 5). On average children on insulin pump therapy had lower mean 
HbA1c compared to those on other therapies (-5 [-2.6%], -6.16 -3.67), Model 4, Table 5.   
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Discussion 
Results from this study indicate that minority ethnicity, deprivation and access to insulin pump therapy are 
each independently associated with poorer glycaemic control in this large national sample. Black and mixed 
ethnicity children had the poorest glycaemic control. Low SES was associated with worse glycaemic control 
in all ethnicities. Whilst the estimates of ethnicity, SES and treatment regimen are smaller in the mutually 
adjusted models, they remain for black and mixed children and are attenuated for Asian children. This 
suggests that for Asians, deprivation and lack of access to pumps maybe the main way in which ethnic 
group membership affects glycaemic control. However, the observed poorer glycaemic control in black and 
mixed children is probably a result of factors not accounted for, such as cultural/lifestyle and/or those 
relating to healthcare access above and beyond insulin pump use. 
Few UK studies have examined the combined effect of ethnicity and SES on glycaemic control in children. 
These studies were smaller in size, restricted to fewer ethnicities, small geographical regions and clinics (4, 
12, 13). Due to small sample sizes, studies also combined all ethnic minorities into one group for 
comparisons with the white group (12). Consistent with our findings, previous UK studies found that 
children of African or black ethnicity and those with greater deprivation (lower SES) had the highest mean 
HbA1c levels or worse glycaemic control (4, 13). However, ours is the first to show the inverse association 
between SES and glycaemic control is present with a dose-effect in most ethnic groups in England and 
Wales. 
This is the largest study to date in the UK to have analysed ethnic and SES differences in glycaemic control 
in children with T1D. It is the first study to analyse differences in glycaemic control in all six major ethnic 
groups corresponding to official standard ethnicity classifications. Additionally, ethnicity is self-identified 
which is considered the ‘gold standard’ in studies on ethnicity and health (22). The IMD scores have been 
shown to be associated with several health outcomes is previous studies and is considered to be the 
standard benchmark for UK governmental health and social policy (23).  
The NPDA data is collected annually by participating paediatric diabetes clinics. Each clinic submits data on 
all participants under their care to a centralised database which helps minimize selection bias. Although the 
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NPDA cannot verify whether 100% of children with diabetes in England and Wales are included in the audit, 
it is estimated to represent in excess of 95% of cases and is nationally representative.  
Previous studies showed that T1D children from single parent households have consistently worse 
glycaemic control compared to those living with both parents, a factor we were unable to account for in 
our analyses (24, 25). The NPDA does not collect data on physical activity and diet which might explain the 
observed differences. We had significant missing data on treatment regimen. However, as sensitivity 
analyses revealed, we believe our results from the sub-analysis on treatment regimen can be generalized to 
the entire study population. 
The category ‘Not Stated’ is used when an individual has been asked for but declined to provide 
information on their ethnicity. However, the NPDA cannot verify that this is the case and it may contain 
individuals where the ethnicity is unknown. This group appeared to be similar to the white group when 
compared on mean HbA1c, age at diagnosis, age at visit, proportion of boys and SES. We observed no 
significant differences between ‘Not stated’ and white groups in regression models indicating that the 
former is composed of mostly white children. However, in the stratified analysis, children with ‘not stated’ 
ethnicity and belonging to the lowest SES groups had much higher mean HbA1c compared to white children 
of the same SES groups (10mmol/mol [3.1%] vs 6mmol/mol [2.7%] respectively). In all likelihood, this group 
is a heterogeneous mix of children belonging to different ethnicities.  
The observed independent association between ethnicity and glycaemic control in this study population 
could be attributed to cultural and lifestyle differences between ethnicities such as diet and physical 
activity which impact on glycaemic control (26). As previously reported, certain ethnic groups might favour 
a particular treatment regimen and older participants might be more reluctant to change to new therapies 
(4). Cultural barriers might lead to less effective communication between healthcare providers and families 
of ethnic minority diabetic children, especially for those that do not have English as their first language. 
Another explanation is the evident lower insulin pump use among ethnic minorities and lower SES groups 
(27). However, accounting for pump use only marginally attenuated the observed ethnicity/SES estimates. 
Observed differences could also reflect in part, biological differences between ethnic groups such as that 
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related to haemoglobin glycation  (28, 29).  Also higher cumulative stress in ethnic minorities might lead to 
alterations in allostatic load (physiologic response to chronic exposure to stress), which in turn influences 
cortisol secretion (30). This can lead to differences in glucose regulation (31).  
 
The National Health Service provides free medical care in the country and thus direct costs of T1D 
treatment should have no bearing on patient’s families and, theoretically, income should not be an 
impediment for access to treatment. For lower SES families, cost of transport to and from clinics is 
reimbursed. However, the relative economic impact of the carer taking time off work is likely to be greater 
in low income families and such losses are not reimbursed. However, the strong differences observed in 
glycaemic control between the lowest and highest SES groups despite free access to healthcare points to 
possible cultural differences in how treatment methods are managed at home or by their clinical team 
and/or to barriers in access to better treatments. Additionally, it appears that SES is a stronger determinant 
of glycaemic control than ethnicity as it was consistently evident in all ethnicities. 
In order to improve glycaemic control, better consideration of the needs of all ethnic groups and those 
belonging to lower SES need to be taken into account. This could involve strengthening the implementation 
of insulin pump therapy, reviewing how healthcare professionals interact with patients and their families, 
and a deeper understanding of cultural difference in attitudes to disease management. Further studies are 
needed to better understand underlying mechanisms which could explain poorer glycaemic control in black 
and mixed ethnicity children. 
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Table 1. Characteristics of the 18,478 children and young people with T1D included in the study by ethnicity 
 Ethnicity 
Characteristics White 
N=13,582 
Asian 
N=874 
Black 
N=323 
Mixed 
N=441 
Other 
N=248 
Not Stated 
N=3,010 
Total 
N=18,478 
P Value** 
Age at visit* 
(years) 
12.86 (3.62) 12.08 (3.86) 11.90 (3.81) 12.02 (3.93) 12.04 (3.93) 12.73 (3.64) 12.76 (3.64) <0.0001 
Age at diagnosis 
(years) 
7.42 (3.87) 6.60 (3.68) 6.85 (3.96) 6.84 (3.81) 6.80 (3.96) 7.57 (3.823) 7.37 (3.86) <0.0001 
Boys (%) 52.9 49.5 47.4 51.9 46.8 51.8 52.4 <0.05 
Diabetes 
duration (years) 
5.44  (3.57) 5.48 (3.60) 5.05 (3.30) 5.18 (3.55) 5.24 (3.57) 5.15 (3.50) 5.38 (3.55) NS 
Mean HbA1c 
(mmol/mol) 
73 (17) 76 (17) 80 (19) 79 (20) 76 (18) 73 (17) 74 (17) <0.0001 
Mean HbA1c (%) 8.8 (3.7) 9.1 (3.7) 9.5 (3.9) 9.4 (4.0) 9.1 (3.8) 8.8 (3.7) 8.9 (3.7) <0.0001 
Socioeconomic 
status  
(IMD score)*** 
20.31 (14.92) 31.56 (16.80)  35.47 (13.78) 27.91 (16.2) 32.31 (16.84) 20.78 (15.45) 21.52 (15.53) <0.0001 
Proportion in 
most deprived 
SES group (IMD 
quintile 5) 
17.1 39.8 52.6 36.3 44 16.4 19.4 <0.0001 
Insulin pump 
therapy (%)+ 
20.3 12.1 5.5 17.4 18.8 5.0 17.3 <0.0001 
Values are means (SD or percentages) 
*Age at first clinic visit in the audit year 
**P values are for a test of equal means or proportions 
***A lower IMD score indicates lower deprivation (or higher socioeconomic status) 
NS – Not statistically Significant. 
+Proportions shown are for a smaller sample of 13,962 children. 
Table 2. Characteristics of 18,478 children and young people with T1D by Socioeconomic Status (IMD quintile) 
 Socioeconomic status – Index of Multiple Deprivation (IMD) 
Characteristics Quintile 1 
N=3,755 
Quintile 2 
N=3,737 
Quintile 3 
N=3,708 
Quintile 4 
N=3,684 
Quintile 5 
N=3,594 
Total 
N=18,478 
P Value** 
Age at visit* (years) 12.87 (3.58) 12.86 (3.65) 12.87 (3.63) 12.62 (3.75) 12.55 (3.67) 12.76 (3.66) <0.001 
Age at diagnosis 
(years) 
7.58 (3.9) 7.45 (3.87) 7.39 (3.82) 7.22 (3.90) 7.23 (3.83) 7.37 (3.86) <0.001 
Boys (%) 53.1 52.7 52.2 52.4 51.4 52.4 NS 
Diabetes duration 
(years) 
5.28 (3.53) 5.40 (3.54) 5.48 (3.58) 5.40 (3.58) 5.31 (3.51) 5.38 (3.55) NS 
Mean HbA1c 
(mmol/mol) 
70 (15) 72 (16) 74 (18) 76 (18) 77 (18) 74 (17) <0.0001 
Mean HbA1c (%) 8.6 (3.5) 8.7 (3.6) 8.9 (3.8) 9.1 (3.8) 9.2 (3.8) 8.9 (3.7) <0.0001 
Insulin pump therapy 
(%)+ 
21.2 20.9 16.9 14.3 13.2 17.3 <0.0001 
 
Values are means (SD or percentages).  
*Age at first clinic visit in the audit year 
**P values are for a test of equal means or proportions 
NS – Not statistically Significant. 
+Proportions shown are for a smaller sample of 13,962 children.
Table 3. Results from multivariate linear regression – assessing effects of ethnicity and SES on glycaemic control in children with type 1 diabetes in England and Wales in 2012-
13 
 Model 1a Model 2b Model 3c 
Ethnicity HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from reference 
(95 % CI) 
White Reference - Reference 
Asian 4            2-5 - 2               0-3 
Black 8            5-11 - 5               3-8 
Mixed 7            5-9 - 6               3-8 
Other 3            1-6 - 1            (-)1-4 
Not Stated 0          (-)1-2 - 0            (-)1-2 
    
Socioeconomic Status  
(IMD quintile) 
   
Quintile 1 - Reference Reference 
Quintile 2 - 2            1-2 2                1-2 
Quintile 3 - 4            3-5 4                3-5 
Quintile 4 - 6            5-8 6                5-7 
Quintile 5 - 7            6-8 7                6-8 
aModel 1: adjusted for age, gender, diabetes duration and ethnicity, R2=0.07 
bModel 2: adjusted for age, gender, diabetes duration and socioeconomic status, R2=0.09 
cModel 3: adjusted for age, gender, diabetes duration, ethnicity and socioeconomic status, R2=0.10 
Text in bold indicates statistical significance at p<0.05 
Table 4. Results from multivariate linear regression – assessing effects of SES on glycaemic control in children with type 1 diabetes in England and Wales in 2012-13, analysis 
stratified by ethnic group  
 Ethnicity 
 White Asian Black Mixed Other Not stated 
Socioeconomic 
Status 
(IMD quintile) 
HbA1c 
(mmol/mol) 
difference  from 
reference (95 % 
CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
Quintile 1 Reference Reference Reference Reference Reference Reference 
Quintile 2 1    1-2 2    (-)3-7 2  (-)12-15 (-)1  (-)6-5 7       (-)3-17 2         0-4 
Quintile 3 4    3-4 6       2-11 6    (-)6-18 4      (-)2-10 6       (-)4-16  5        3-7 
Quintile 4 6    5-7 5       0-10 7    (-)5-18 12    6-18 10      1-19 7        5-10 
Quintile 5 6   5-7 7       3-11 4    (-)6-14 11    6-16 9        0-18 10     8-13 
P* <0.001 <0.001 N.S. <0.001 N.S. <0.001 
 
All models adjusted for age, gender and diabetes duration 
*Test for trend 
N.S. – Statistically Not Significant 
Text in bold indicates statistical significance at p<0.05 
  
Table 5. Results from multivariate linear regression – assessing effects of ethnicity and SES on glycaemic control in 13,962 children with type 1 diabetes in England and Wales in 
2012-13 and data on treatment regimen 
 Model 1a Model 2b Model 3c Model 4d 
Ethnicity HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from 
reference (95 % CI) 
HbA1c (mmol/mol) 
difference  from reference 
(95 % CI) 
White Reference - Reference Reference 
Asian 3            1-4 - 1            (-)0-3 1             (-)1-3 
Black 7            5-10 - 5               2-8 5                2-8 
Mixed 7            4-9 - 6               3-8 5                3-8 
Other 3            0-6 - 1            (-)1-4 1             (-)2-4 
Not Stated 1           (-)1.03-2.37 - 1            (-)1-2 0             (-)2-1 
     
Socioeconomic Status  
(IMD quintile) 
    
Quintile 1 - Reference Reference Reference 
Quintile 2 - 1            0-2 1                0-2 1                0-2 
Quintile 3 - 3            2-4 3                2-4 3                2-4 
Quintile 4 - 6            5-7 5                4-7 5                4-6 
Quintile 5 - 7            5-8 6                5-7 6                5-7 
     
Insulin pump     
No - - - Reference 
Yes - - - (-)5      (-)6-(-)4 
 
aModel 1: adjusted for age, gender, diabetes duration and ethnicity, R2=0.07 
bModel 2: adjusted for age, gender, diabetes duration and socioeconomic status, R2=0.08 
cModel 3: adjusted for age, gender, diabetes duration, ethnicity and socioeconomic status, , R2=0.09 
dModel 4: adjusted for age, gender, diabetes duration, ethnicity and socioeconomic status and pump therapy, R2=0.10 
Text in bold indicates statistical significance at p<0.05
